ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 153 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2017. The put-call ratio across all filers is 2.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $141,447,000 | -9.4% | 3,522,964 | +3.8% | 3.56% | -28.9% |
| Q4 2018 | $156,076,000 | +7.1% | 3,392,964 | +3.4% | 5.00% | +29.7% |
| Q3 2018 | $145,665,000 | +16.8% | 3,282,964 | +3.1% | 3.86% | +7.0% |
| Q2 2018 | $124,740,000 | -28.5% | 3,182,964 | +31.9% | 3.60% | -25.3% |
| Q1 2018 | $174,530,000 | +12.2% | 2,412,964 | +2.1% | 4.82% | +10.1% |
| Q4 2017 | $155,578,000 | +48.0% | 2,362,964 | +12.6% | 4.38% | +50.5% |
| Q3 2017 | $105,150,000 | +50.1% | 2,097,964 | +38.6% | 2.91% | +36.0% |
| Q2 2017 | $70,047,000 | +40.8% | 1,513,542 | +7.5% | 2.14% | +31.6% |
| Q1 2017 | $49,736,000 | +203.6% | 1,408,542 | +7.6% | 1.63% | +168.0% |
| Q4 2016 | $16,383,000 | -9.6% | 1,308,542 | 0.0% | 0.61% | -4.7% |
| Q3 2016 | $18,123,000 | +81.9% | 1,308,542 | +29.7% | 0.64% | +62.1% |
| Q2 2016 | $9,964,000 | -41.6% | 1,008,542 | 0.0% | 0.39% | -42.0% |
| Q1 2016 | $17,054,000 | -15.7% | 1,008,542 | +11.0% | 0.68% | +18.9% |
| Q4 2015 | $20,224,000 | -5.6% | 908,542 | 0.0% | 0.57% | -16.2% |
| Q3 2015 | $21,433,000 | – | 908,542 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |